A cellular platform for the evaluation of immune checkpoint molecules-Reference-Cited by-同舟云学术

A cellular platform for the evaluation of immune checkpoint molecules

Published:2017-05-04 Issue:39 Volume:8 Page:64892-64906
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Jutz Sabrina¹,Hennig Annika¹,Paster Wolfgang¹,Asrak Ömer¹,Dijanovic Dejana¹,Kellner Florian²,Pickl Winfried F.³,Huppa Johannes B.²,Leitner Judith¹,Steinberger Peter¹

Affiliation:

1. Division of Immune Receptors and T cell Activation, Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria

2. Department of Molecular Immunology, Immune Recognition Unit, Institute for Hygiene and Applied Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria

3. Division of Cellular Immunology and Immunohematology, Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of bioassay platforms for biopharmaceuticals using Jurkat-CAR cells by AICD;Journal of Pharmaceutical and Biomedical Analysis;2024-12

2. HIV-1 Vpr-induced DNA damage activates NF-κB through ATM-NEMO independent of cell cycle arrest;mBio;2024-09-13

3. BTLA and PD-1 signals attenuate TCR-mediated transcriptomic changes;iScience;2024-07

4. The CD6 interactome orchestrates ligand-independent T cell inhibitory signaling;Cell Communication and Signaling;2024-05-24

5. Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation;Proceedings of the National Academy of Sciences;2024-05-21